S&S has experience across a range of conditions relevant to pharma and biopharma, spanning IBS to oncology and beyond. Our in-depth qualitative understandings of the medical landscape and quantitative analysis of portfolio competitiveness in these areas allows us to help clients improve their market positioning.
For example, it can be challenging for B2B pharma players, or those who have set up a network of local distribution partnerships, to influence patient journeys, communications with HCPs and patients, and ultimately product choice. We work closely with these types of players to ensure they transmit the right information to their partners and customers to drive more business.
Autoimmune Diseases (Lupus, Primary Humoral Immunodeficiency, Rheumatoid Arthritis)
Cancer (Breast, Lower/Upper GI, Head & Neck, Prostate, Lung, Uterine)
Diabetes Type 1/2
Infectious Respiratory Diseases
Inflammatory Bowel Diseases
Published on19 September 2023
Published on18 September 2023
Published on17 September 2023
Sector & Segment takes pride in being experts in a range of healthcare solutions, understanding the unique market dynamics, competitive ecosystems, and regulatory regimes that define the healthcare landscape. This allows us to offer highly specific solutions according to the challenges and knowledge needs of our clients.Know More
Sector & Segment has experience navigating the challenges of specific therapeutic areas, including identifying patient needs, HCP preferences, and pain points. This expertise allows us to effectively conduct research and support clients in improving their market positioning.Know More